Gene content    
KRIT1 ( by HUGO)
KRIT1, Ankyrin Repeat Containing
Tumor suppressor gene
KRIT1
Ankyrin Repeat Containing
CCM1
Cerebral Cavernous Malformations 1 Protein
Krev Interaction Trapped 1
CAM
Cerebral Cavernous Malformations 1
Ankyrin Repeat-Containing Protein Krit1
Krev Interaction Trapped Protein 1
NCBI: 7q21.2    Ensembl: 7q21.2
KRIT1_HUMANSize: 736 amino acidsMass: 84348 Da

  • Subunit: Interacts with CDH5 (By similarity). Found in a complex, at least composed of ITGB1BP1, KRIT1 and RAP1A. Interacts (via C-terminus FERM domain) with RAP1A (active GTP-bound form preferentially); the interaction does not induce the opening conformation of KRIT1. Interacts (via FERM domain) with RAP1B. Interacts (via N-terminus NPXY motif) with ITGB1BP1; the interaction induces the opening conformation of KRIT1 and competes with ITGB1 for ITGB1BP1 interaction. Interacts with HEG1 and CCM2; greatly facilitates CCM2-binding to HEG1. Associates (via N-terminus and C-terminus regions) with microtubules; the interaction is inhibited in presence of ITGB1BP1 and active GTP-bound RAP1A 6 PDB 3D structures from [IMAGE] and Proteopedia [IMAGE] for KRIT1: 3U7D (3D) [IMAGE] 4DX8 (3D) [IMAGE] 4DXA (3D) [IMAGE] 4HDO (3D) [IMAGE] 4HDQ (3D) [IMAGE] 4JIF (3D) [IMAGE]
  • Tissue specificity: Low levels in brain. Very weak expression found in heart and muscle [IMAGE] Pathway & Disease-focused RT2 Profiler PCR Array including KRIT1: Telomeres & Telomerase in human mouse rat Primer Products: [IMAGE] OriGene qPCR primer pairs and template standar
  • Function:
    UniProtKB/Swiss-Prot Summary: KRIT1_HUMAN, O00522 Function: Component of the CCM signaling pathway which is a crucial regulator of heart and vessel formation and integrity (By similarity). Negative regulator of angiogenesis. Inhibits endothelial proliferation, apoptosis, migration, lumen formation and sprouting angiogenesis in primary endothelial cells. Promotes AKT phosphorylation in a NOTCH-dependent and independent manner, and inhibits ERK1/2 phosphorylation indirectly through activation of the DELTA-NOTCH cascade. Acts in concert with CDH5 to establish and maintain correct endothelial cell polarity and vascular lumen and these effects are mediated by recruitment and activation of the Par polarity complex and RAP1B. Required for the localization of phosphorylated PRKCZ, PARD3, TIAM1 and RAP1B to the cell junction, and cell junction stabilization. Plays a role in integrin signaling via its interaction with ITGB1BP1; this prevents the interaction between ITGB1 and ITGB1BP1. Microtubule-associated protein that binds to phosphatidylinositol 4,5-bisphosphate (PIP2)-containing membranes in a GTP-bound RAP1-dependent manner. Plays an important role in the maintenance of the intracellular reactive oxygen species (ROS) homeostasis to prevent oxidative cellular damage. Regulates the homeostasis of intracellular ROS through an antioxidant pathway involving FOXO1 and SOD2. Facilitates the down-regulation of cyclin-D1 (CCND1) levels required for cell transition from proliferative growth to quiescence by preventing the accumulation of intracellular ROS through the modulation of FOXO1 and SOD2 levels
  • Similarity:
    Contains 4 ANK repeats
                          
    Contains 1 FERM domain [IMAGE]
  • Protein Domain/Family    
    Source ID Domain Name Type
    InterProIPR000299FERM_domainBand 4.1Domain
    IPR002110Ankyrin_rptAnkyrinRepeat
    BlocksIPB002110Ankyrin repeat signatureAnkyrin repeat signature

    Gene Ontology    
    Type Term Evidence Source Pub
    Biological Process regulation of catalytic activity TAS GOA 9285558
    small GTPase mediated signal transduction TAS GOA 9285558
    Cellular Component microtubule IDA GOA 17916086
    plasma membrane IDA GOA 17916086
    Molecular Function microtubule binding IDA GOA 17916086
    phosphatidylinositol-4,5-bisphosphate binding IDA GOA 17916086
    protein binding IPI GOA 16037064
    protein complex binding IDA GOA 17916086
    small GTPase regulator activity TAS GOA 9285558

    Disorder & Mutation    
    Source Disease
    SWISS-PROTCerebral cavernous malformations 1 (CCM1) [MIM:116860]: A congenital vascular anomaly of the central nervous system that can result in hemorrhagic stroke, seizures, recurrent headaches, and focal neurologic deficits. The lesions are characterized by grossly enlarged blood vessels consisting of a single layer of endothelium and without any intervening neural tissue, ranging in diameter from a few millimeters to several centimeters. Note=The disease is caused by mutations affecting the gene represented in this entry

    KRIT1 cross reference    
    PubMed OMIM Entrez Gene NCKU SNP Nucleotide UniProt Genome Data Viewer HomoloGene